Molecular and biochemical mechanisms of diabetic encephalopathy

被引:7
|
作者
Belenichev, Igor [1 ]
Aliyeva, Olena [2 ]
Popazova, Olena [3 ]
Bukhtiyarova, Nina [4 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Dept Pharmacol & Med Formulat Course Normal Physio, Zaporizhzhia, Ukraine
[2] Zaporizhzhia State Med & Pharmaceut Univ, Dept Med Biol Parasitol & Genet, Zaporizhzhia, Ukraine
[3] Zaporizhzhia State Med & Pharmaceut Univ, Dept Histol Cytol & Embryol, Zaporizhzhia, Ukraine
[4] Zaporizhzhia State Med & Pharmaceut Univ, Dept Clin Lab Diagnost, Zaporizhzhia, Ukraine
关键词
diabetes mellitus; diabetic encephalopathy; thiol-di-sulfide system; mitochondrial dysfunction; HSP70; HIF-1a; GROWTH-FACTOR-I; MITOCHONDRIAL DYSFUNCTION; CEREBRAL-ISCHEMIA; COMPLICATIONS; HSP70; EXPRESSION; MELLITUS; RECEPTOR; STRESS; HIPPOCAMPUS;
D O I
10.18388/abp.2020_6953
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes mellitus is one of the important independent risk factors for the development of neurological disorders such as ischemic stroke, transient ischemic attacks, vascular dementia and neurodegenerative processes. Hyperglycemia plays a crucial role as a trigger in the pathogenesis of these disorders. In this review, we summarize the existing data on the molecular mechanisms of diabetic encephalopathy development, consider the features of oxidative and nitrosative stresses, changes in the thiol-disulfide system, as well as mitochondrial and endothelial dysfunction in diabetes. We focus on the role of HSP 70 in cellular responses in diabetic encephalopathy. HSP70 protein is an important component of the endogenous system of neuroprotection. It acts as an intracellular chaperone, providing the folding, retention, and transport of synthesized proteins, as well as their degradation under both normoxic and stress-induced denaturation conditions. HSP70 can be considered a molecular marker and a promising therapeutic target in the treatment of diabetes mellitus.
引用
收藏
页码:751 / 760
页数:10
相关论文
共 50 条
  • [1] Biochemical and molecular mechanisms of diabetic retinopathy
    Balasubramanyam, M
    Rema, M
    Premanand, C
    CURRENT SCIENCE, 2002, 83 (12): : 1506 - 1514
  • [2] MOLECULAR AND BIOCHEMICAL MECHANISMS OF DIABETIC COMPLICATIONS
    Gillery, P.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S38 - S38
  • [3] Biochemical and molecular mechanisms in the development of diabetic vascular complications
    King, GL
    Kunisaki, M
    Nishio, Y
    Inoguchi, T
    Shiba, T
    Xia, P
    DIABETES, 1996, 45 : S105 - S108
  • [4] G-PROTEINS AND DIABETIC ENCEPHALOPATHY - MOLECULAR MECHANISMS UNDERLYING THE FUNCTIONAL ALTERATIONS
    FINCO, C
    ABBRACCHIO, MP
    PATERNIERI, B
    CATTABENI, F
    DIGIULIO, AM
    MALOSIO, ML
    MANTEGAZZA, P
    GORIO, A
    PHARMACOLOGICAL RESEARCH, 1992, 25 : 109 - 110
  • [5] BIOCHEMICAL-MECHANISMS OF HEPATIC-ENCEPHALOPATHY
    CROSSLEY, IR
    WARDLE, EN
    WILLIAMS, R
    CLINICAL SCIENCE, 1983, 64 (03) : 247 - 252
  • [6] Advances in biochemical mechanisms of diabetic retinopathy
    Giusti, C.
    Gargiulo, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2007, 11 (03) : 155 - 163
  • [7] Molecular mechanisms in the pathogenesis of AIDS encephalopathy
    Schwartz, SA
    Nair, MPN
    CELLULAR AND MOLECULAR BIOLOGY, 1997, 43 (07) : 925 - 933
  • [8] Molecular mechanisms of chronic traumatic encephalopathy
    van den Bedem, Henry
    Kuhl, Ellen
    CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2017, 1 : 23 - 30
  • [9] Biochemical and molecular mechanisms of gastroprotection
    Fischer, H
    Konturek, JW
    Domschke, W
    LEBER MAGEN DARM, 1998, 28 (01) : 13 - 18
  • [10] Molecular and biochemical mechanisms in teratogenesis
    Wells, PG
    Bhuller, Y
    Chen, CS
    Jeng, W
    Kasapinovic, S
    Kennedy, JC
    Laposa, RR
    McCallum, GP
    Nicol, CJ
    Parman, T
    Wiley, MJ
    Wong, AW
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 162 - 163